FR3003761B1 - Utilisation d'une lactone macrocyclique pour le traitement d'une infection par un papillomavirus - Google Patents

Utilisation d'une lactone macrocyclique pour le traitement d'une infection par un papillomavirus

Info

Publication number
FR3003761B1
FR3003761B1 FR1352855A FR1352855A FR3003761B1 FR 3003761 B1 FR3003761 B1 FR 3003761B1 FR 1352855 A FR1352855 A FR 1352855A FR 1352855 A FR1352855 A FR 1352855A FR 3003761 B1 FR3003761 B1 FR 3003761B1
Authority
FR
France
Prior art keywords
papillomavirus
infection
treatment
macrocyclic lactone
macrocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1352855A
Other languages
English (en)
Other versions
FR3003761A1 (fr
Inventor
Jean Jacovella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Priority to FR1352855A priority Critical patent/FR3003761B1/fr
Priority to EP14714683.1A priority patent/EP2978424A1/fr
Priority to US14/780,314 priority patent/US10376492B2/en
Priority to PCT/EP2014/056374 priority patent/WO2014154899A1/fr
Publication of FR3003761A1 publication Critical patent/FR3003761A1/fr
Application granted granted Critical
Publication of FR3003761B1 publication Critical patent/FR3003761B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR1352855A 2013-03-29 2013-03-29 Utilisation d'une lactone macrocyclique pour le traitement d'une infection par un papillomavirus Expired - Fee Related FR3003761B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1352855A FR3003761B1 (fr) 2013-03-29 2013-03-29 Utilisation d'une lactone macrocyclique pour le traitement d'une infection par un papillomavirus
EP14714683.1A EP2978424A1 (fr) 2013-03-29 2014-03-28 Utilisation d'une lactone macrocyclique pour le traitement d'une complication d'une infection par un papillomavirus
US14/780,314 US10376492B2 (en) 2013-03-29 2014-03-28 Use of a macrocyclic lactone for treating a complication from a papilloma virus infection
PCT/EP2014/056374 WO2014154899A1 (fr) 2013-03-29 2014-03-28 Utilisation d'une lactone macrocyclique pour le traitement d'une complication d'une infection par un papillomavirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1352855A FR3003761B1 (fr) 2013-03-29 2013-03-29 Utilisation d'une lactone macrocyclique pour le traitement d'une infection par un papillomavirus

Publications (2)

Publication Number Publication Date
FR3003761A1 FR3003761A1 (fr) 2014-10-03
FR3003761B1 true FR3003761B1 (fr) 2016-01-01

Family

ID=48795679

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1352855A Expired - Fee Related FR3003761B1 (fr) 2013-03-29 2013-03-29 Utilisation d'une lactone macrocyclique pour le traitement d'une infection par un papillomavirus

Country Status (4)

Country Link
US (1) US10376492B2 (fr)
EP (1) EP2978424A1 (fr)
FR (1) FR3003761B1 (fr)
WO (1) WO2014154899A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05011208A (es) * 2003-04-24 2005-12-14 Galderma Sa Uso de ivermectina para el tratamiento de desordenes dermatologicos.
JP2012513387A (ja) * 2008-12-23 2012-06-14 ガルデルマ・ソシエテ・アノニム 感水性の活性成分を含む、局所用医薬組成物
EP2629612B1 (fr) * 2010-10-20 2015-07-15 Galderma S.A. Procédé de traitement d'une infection par le virus de l'herpès utilisant un composé lactone macrocyclique
WO2012150543A1 (fr) 2011-05-02 2012-11-08 Universite De Geneve Lactones macrocycliques et leur utilisation

Also Published As

Publication number Publication date
US10376492B2 (en) 2019-08-13
EP2978424A1 (fr) 2016-02-03
FR3003761A1 (fr) 2014-10-03
WO2014154899A1 (fr) 2014-10-02
US20160051508A1 (en) 2016-02-25

Similar Documents

Publication Publication Date Title
HK1246296A1 (zh) 多環氨基甲酰基吡啶酮化合物和其用於治療hiv感染的用途
HK1223615A1 (zh) 多環氨基甲酰基吡啶酮化合物和其用於治療 感染的用途
MA45539A (fr) Dihydropyranopyrimidines pour le traitement d'infections virales
IL240765A0 (en) Macrocyclic daza-furanones for the treatment of viral infections
EP2968362A4 (fr) Isomère de béraprost en tant qu'agent pour le traitement d'infection virale
DK3003307T3 (da) Kombinationsterapi omfattende oxazolidinon-quinoloner til anvendelse i behandling af bakterieinfektioner
FR20C1044I2 (fr) Triazines pour le traitement des infections protozoïques
FR3013184B1 (fr) Utilisation d'hydroxyapatite pour le traitement de l'esca
MA43570A (fr) Thérapie génique pour traiter l'hypercholestérolémie familiale
FR3015285B1 (fr) Formulation pour le traitement des cheveux
FR3002146B1 (fr) Utilisation d'hemoglobine d'annelides pour traiter les cancers
FR3018897B3 (fr) Structure lineaire encastrable pour l'illumination
FR3010635B1 (fr) Compositions pharmaceutiques a base d'agent filmogene pour le traitement de l'hyposialie
ITRM20120473A1 (it) Use of glycerophosphoinositols for the treatment of septic shock
FR3003761B1 (fr) Utilisation d'une lactone macrocyclique pour le traitement d'une infection par un papillomavirus
FR3000399B1 (fr) Utilisation topique du laropiprant pour le traitement de la rosacee
FR3014422B1 (fr) Ecarteur d'elingues
FR3005577B1 (fr) Traitement de l'inconfort buccal
FR2987047B1 (fr) Utilisations des derives de carbazolophenones pour le traitement du cancer.
FR3003452B1 (fr) Table relevable pour le traitement de petits animaux
FR2992863B1 (fr) Composition pharmaceutique pour le traitement du cancer
MA41295A (fr) Utilisation d'analogues de l'ion pyrophosphate pour le traitement de l'infection par vph
FR3022457B1 (fr) Utilisation de cannabis pour le traitement de l'achalasie
FR3006339B3 (fr) Dispositif pour le traitement optimal du ballast de caillasse
ITFI20130045U1 (it) Dispositivo per l'azionamento di espansori palatali.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

ST Notification of lapse

Effective date: 20201109